[go: up one dir, main page]

DE60128800D1 - Hydrophobe iodverbindung enthaltende liposome - Google Patents

Hydrophobe iodverbindung enthaltende liposome

Info

Publication number
DE60128800D1
DE60128800D1 DE60128800T DE60128800T DE60128800D1 DE 60128800 D1 DE60128800 D1 DE 60128800D1 DE 60128800 T DE60128800 T DE 60128800T DE 60128800 T DE60128800 T DE 60128800T DE 60128800 D1 DE60128800 D1 DE 60128800D1
Authority
DE
Germany
Prior art keywords
hydrophobic
compound containing
containing liposome
liposome
iodic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128800T
Other languages
English (en)
Other versions
DE60128800T2 (de
Inventor
Kazuhiro Aikawa
Hiroshi Kitaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of DE60128800D1 publication Critical patent/DE60128800D1/de
Application granted granted Critical
Publication of DE60128800T2 publication Critical patent/DE60128800T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461Dispersions, colloids, emulsions or suspensions
    • A61K49/0466Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE60128800T 2000-04-28 2001-04-26 Hydrophobe iodverbindung enthaltende liposome Expired - Lifetime DE60128800T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000130069 2000-04-28
JP2000130069 2000-04-28
JP2001018573 2001-01-26
JP2001018573 2001-01-26
PCT/JP2001/003629 WO2001082977A1 (en) 2000-04-28 2001-04-26 Liposomes containing hydrophobic iodo compound

Publications (2)

Publication Number Publication Date
DE60128800D1 true DE60128800D1 (de) 2007-07-19
DE60128800T2 DE60128800T2 (de) 2008-02-07

Family

ID=26591162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128800T Expired - Lifetime DE60128800T2 (de) 2000-04-28 2001-04-26 Hydrophobe iodverbindung enthaltende liposome

Country Status (9)

Country Link
US (1) US7101532B2 (de)
EP (1) EP1284146B1 (de)
KR (1) KR100824068B1 (de)
AT (1) ATE363920T1 (de)
AU (2) AU5260301A (de)
CA (1) CA2407654C (de)
DE (1) DE60128800T2 (de)
NZ (1) NZ522457A (de)
WO (1) WO2001082977A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1287833B1 (de) * 2001-08-20 2007-10-10 FUJIFILM Corporation Hydrophobe Iodverbindung enthaltendes Liposom und dieses enthaltendes Röntgenkontrastmittel
US7264790B2 (en) * 2001-08-23 2007-09-04 Fujifilm Corporation 1,3-glyceride compound having two iodophenyl groups
JP2004064636A (ja) * 2002-07-31 2004-02-26 Fuji Photo Film Co Ltd サブトラクション画像形成方法
JP2004115397A (ja) * 2002-09-25 2004-04-15 Fuji Photo Film Co Ltd 血管疾患治療薬を含むリポソーム
US7216038B2 (en) 2003-09-11 2007-05-08 Franco Vitaliano Quantum information processing elements and quantum information processing platforms using such elements
US7219017B2 (en) 2003-09-11 2007-05-15 Franco Vitaliano Quantum information processing elements and quantum information processing platforms using such elements
US7219018B2 (en) * 2003-09-11 2007-05-15 Franco Vitaliano Quantum information processing elements and quantum information processing platforms using such elements
US7393924B2 (en) * 2004-01-06 2008-07-01 Franco Vitaliano Smart bio-nanoparticle elements
US20060239925A1 (en) * 2005-04-21 2006-10-26 Konica Minolta Medical & Graphic, Inc. Method of manufacturing pharmaceutical preparation containing liposomes
JP2006335745A (ja) * 2005-06-06 2006-12-14 Fujifilm Holdings Corp リポソームを含むmri造影剤
US11235062B2 (en) * 2009-03-06 2022-02-01 Metaqor Llc Dynamic bio-nanoparticle elements
US11096901B2 (en) 2009-03-06 2021-08-24 Metaqor Llc Dynamic bio-nanoparticle platforms
JP6867639B2 (ja) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 非イオン性ヨード造影剤の結合体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
GB2157283B (en) * 1984-03-30 1987-07-08 Squibb & Sons Inc Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
AU4789096A (en) * 1995-02-09 1996-08-27 Schering Aktiengesellschaft Liposomes containing contrast media for blood pool imaging
ATE207763T1 (de) * 1995-02-24 2001-11-15 Bracco Research Sa Liposomensuspensionen als blut-pool- kontrastmittel
AU5187696A (en) * 1995-03-09 1996-10-02 Nanosystems L.L.C. Nanoparticulate diagnostic triiodo benzoate derivatives as x-ray contrast agents for blood pool and lymphatic system imaging

Also Published As

Publication number Publication date
AU2001252603B2 (en) 2005-10-13
US20030180220A1 (en) 2003-09-25
AU5260301A (en) 2001-11-12
CA2407654C (en) 2009-06-30
NZ522457A (en) 2004-07-30
EP1284146B1 (de) 2007-06-06
EP1284146A4 (de) 2004-12-22
CA2407654A1 (en) 2002-10-28
DE60128800T2 (de) 2008-02-07
WO2001082977A1 (en) 2001-11-08
KR20020093957A (ko) 2002-12-16
ATE363920T1 (de) 2007-06-15
EP1284146A1 (de) 2003-02-19
US7101532B2 (en) 2006-09-05
KR100824068B1 (ko) 2008-04-21

Similar Documents

Publication Publication Date Title
DE60128800D1 (de) Hydrophobe iodverbindung enthaltende liposome
DK1056477T3 (da) Naopartikler omfattende polyisobutylcyanoacrylat og cyclodextriner
AU2002220651A1 (en) Steerable loop structure
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
ES2174465T3 (es) Compuestos triazol y su utilizacion como ligandos de dopamina-d.
CY1114535T1 (el) Ρετινοειδη παραγωγα με αντιαγγειογονικες, αντιογκικες και προαποπτωτικες δραστικοτητες
BRPI0402760A (pt) Composição microbicida
ATE364198T1 (de) 1,3-dihydro-1-oxo-2h-indenderivat
FI923273A0 (fi) Med dubbelminne foersett multiprocessorsystem.
ATE218816T1 (de) Chemoschützende nahrungsmittel gegen krebs
DE69105462D1 (de) Desinfizierende Zusammensetzung.
WO2002028472A3 (en) Non-scatterable, radio-opaque marker for medical imaging applications
YU40891A (sh) Podloga za kontrastno sredstvo
ITTO910599A0 (it) Amplificatore,particolarmente amplificatore integrato.
DE69320339D1 (de) Derivate des Dolastatin
ITMI910857A0 (it) Composizione acquosa gelificabile utile per modificare la permeabilita' in un giacimento petrolifero
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
NO965301D0 (no) 2,4,6-trijod-5-substituerte-amino-isoftalatestere nyttige som röntgenkontrastmidler for medisinsk diagnostisk billeddannelse
DK1073447T3 (da) N1-modificerede glycopeptider
SV2004001441A (es) Compuestos de isocromano ref. x-14205
AU4461496A (en) The use of heterocyclic compounds as antioxidants, radical scavengers, fe2+ complexing agents, tissue- and/or neuroprotectants
FI923088A0 (fi) Oktadekyl-(2-(n-metylpiperidino)- etyl)-fosfat och foerfarande foer dess framstaellning.
ATE375173T1 (de) Hydrophobe iodverbindung enthaltendes liposom und dieses enthaltendes röntgenkontrastmittel
RU2000118409A (ru) Антимутагенное средство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition